Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage

被引:14
作者
Harn, HJ
Hsieh, HF
Ho, LI
Yu, CP
Chen, JH
Chiu, CC
Fan, HC
Lee, WH
机构
[1] Tri Serv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Army Hosp 804, Taipei, Taiwan
[2] Tri Serv Gen Hosp, Dept Surg, Natl Def Med Ctr, Army Hosp 804, Taipei, Taiwan
[3] Tri Serv Gen Hosp, Sch Dent, Natl Def Med Ctr, Army Hosp 804, Taipei, Taiwan
[4] Vet Gen Hosp, Sect Resp Care, Taipei, Taiwan
关键词
apoptosis; bcl-2; Ki67; nasopharyngeal carcinoma; p53;
D O I
10.1046/j.1365-2559.1998.00470.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: We investigated the significance of apoptosis, using the terminal deoxynucleotidyl transferase mediated dUTP-digoxigenin nick end-labelling method, in nasopharyngeal carcinoma biopsy samples. Methods and results: The apoptotic index (AT) in 50 nasopharyngeal carcinomas was compared with various histopathological features and clinical stage, Also, the AI was correlated with p53, bcl-2 and Ki67 expression by immunohistochemistry. In histopathological studies, the AI was significantly higher in mixed cellular type (MC) than in keratizing squamous cell type (KS) and spindle cell type (SC) (P<0.001) which worsens prognosis. In tumour stage analyses, AI was higher in early stage (stage 2 and 3) than in high stage (stage 4). In addition, there was a significant correlation between the AI and p53 expression (P < 0.001) but not with proliferative activity (P = 0.15), In NPC containing p53 protein positive tumour cells, there was a significantly higher apoptotic rate. Conclusions: These findings indicate that apoptosis is related to type and stage of nasopharyngeal carcinoma, They also confirm the role of p53 in regulating tumour apoptosis.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 30 条
[1]  
ARENDS MJ, 1990, AM J PATHOL, V136, P593
[2]   p53 in signaling checkpoint arrest or apoptosis [J].
Bates, S ;
Vousden, KH .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :12-18
[3]   Apoptosis [J].
Cummings, MC ;
Winterford, CM ;
Walker, NI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (01) :88-101
[4]   The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma [J].
Dada, MA ;
Chetty, R ;
Biddolph, SC ;
Schneider, JW ;
Gatter, KC .
HISTOPATHOLOGY, 1996, 29 (02) :159-163
[5]   ALTERATIONS OF THE P53 GENE IN NASOPHARYNGEAL CARCINOMA [J].
EFFERT, P ;
MCCOY, R ;
ABDELHAMID, M ;
FLYNN, K ;
ZHANG, Q ;
BUSSON, P ;
TURSZ, T ;
LIU, E ;
RAABTRAUB, N .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3768-3775
[6]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[7]   PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION [J].
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
STEIN, H .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) :13-20
[8]  
GORXZUCA W, 1995, ARCHOWS ARCH, V426, P229
[9]   Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues [J].
Harn, HJ ;
Ho, LI ;
Liu, CA ;
Liu, GC ;
Lin, FG ;
Lin, JJ ;
Lee, WH .
HISTOPATHOLOGY, 1996, 28 (04) :317-323
[10]  
HENLE W, 1970, J NATL CANCER I, V44, P225